NASDAQ:NTBL Notable Labs (NTBL) Stock Price, News & Analysis $0.25 -0.09 (-26.64%) (As of 10/22/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends About Notable Labs Stock (NASDAQ:NTBL) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Notable Labs alerts:Sign Up Key Stats Today's Range$0.24▼$0.3150-Day Range$0.24▼$0.6452-Week Range$0.22▼$4.24Volume2.11 million shsAverage Volume1.01 million shsMarket Capitalization$2.39 millionP/E RatioN/ADividend YieldN/APrice Target$7.00Consensus RatingModerate Buy Company OverviewNotable Labs, Ltd., a clinical-stage platform therapeutics company, develops predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient will clinically respond to their actual treatment. Its PPMP is designed to identify and select clinically responsive patients prior to their treatment and enables fast-track therapeutic development in this patient population. The company's pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor to induce cell cycle arrest and apoptosis in various cancer cells; and Fosciclopirox, a pro-drug of ciclopirox for acute myeloid leukemia. Notable Labs, Ltd. was incorporated in 2014 and is headquartered in Foster City, California.Read More… Watch this before it gets removed (Ad)If you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. Notable Labs Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks47th Percentile Overall ScoreNTBL MarketRank™: Notable Labs scored higher than 47% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.3 / 5Analyst RatingModerate Buy Consensus RatingNotable Labs has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.Amount of Analyst CoverageNotable Labs has only been the subject of 1 research reports in the past 90 days.Read more about Notable Labs' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Book Value per Share RatioNotable Labs has a P/B Ratio of 0.04. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Notable Labs' valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted9.71% of the float of Notable Labs has been sold short.Short Interest Ratio / Days to CoverNotable Labs has a short interest ratio ("days to cover") of 6.2.Change versus previous monthShort interest in Notable Labs has recently decreased by 19.29%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldNotable Labs does not currently pay a dividend.Dividend GrowthNotable Labs does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted9.71% of the float of Notable Labs has been sold short.Short Interest Ratio / Days to CoverNotable Labs has a short interest ratio ("days to cover") of 6.2.Change versus previous monthShort interest in Notable Labs has recently decreased by 19.29%, indicating that investor sentiment is improving significantly. News and Social Media1.6 / 5News SentimentN/A News SentimentNotable Labs has a news sentiment score of -0.13. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.41 average news sentiment score of Medical companies.Search InterestOnly 2 people have searched for NTBL on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.MarketBeat Follows3 people have added Notable Labs to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Notable Labs insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.20% of the stock of Notable Labs is held by insiders.Percentage Held by Institutions70.48% of the stock of Notable Labs is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Notable Labs' insider trading history. Receive NTBL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Notable Labs and its competitors with MarketBeat's FREE daily newsletter. Email Address NTBL Stock News HeadlinesHead to Head Review: Pieris Pharmaceuticals (NASDAQ:PIRS) versus Notable Labs (NASDAQ:NTBL)October 17, 2024 | americanbankingnews.comNotable Labs Pauses Implementation of Cancer Drug Volasertib Study, Announces LayoffsSeptember 20, 2024 | marketwatch.comWatch this before it gets removed If you missed it, my emergency election broadcast is now available - but will be removed soonOctober 24, 2024 | Porter & Company (Ad)Notable Labs (NTBL) was downgraded to a Hold Rating at JMP SecuritiesSeptember 20, 2024 | markets.businessinsider.comNotable Labs to Present Data on September 4th at SOHO 2024August 29, 2024 | globenewswire.comNotable Labs Announces CEO TransitionAugust 27, 2024 | finance.yahoo.comNTBL Stock Earnings: Notable Labs Misses EPS for Q2 2024August 16, 2024 | investorplace.comLA’s best burrito is a lab-engineered marvelAugust 15, 2024 | msn.comSee More Headlines NTBL Stock Analysis - Frequently Asked Questions How have NTBL shares performed this year? Notable Labs' stock was trading at $1.89 at the start of the year. Since then, NTBL stock has decreased by 86.9% and is now trading at $0.2479. View the best growth stocks for 2024 here. How were Notable Labs' earnings last quarter? Notable Labs, Ltd. (NASDAQ:NTBL) released its quarterly earnings results on Wednesday, August, 14th. The company reported ($0.55) EPS for the quarter. How do I buy shares of Notable Labs? Shares of NTBL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Notable Labs own? Based on aggregate information from My MarketBeat watchlists, some other companies that Notable Labs investors own include Algonquin Power & Utilities (AQN), LiveOne (LVO), Palatin Technologies (PTN), Frontier Group (ULCC), Adverum Biotechnologies (ADVM), Sirius XM (SIRI) and Clearside Biomedical (CLSD). Company Calendar Last Earnings8/14/2024Today10/23/2024Next Earnings (Estimated)11/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:NTBL Previous SymbolNASDAQ:NTBL CUSIPN/A CIK1603207 Webwww.vblrx.com Phone(728) 993-5000Fax972-8993-5001Employees40Year FoundedN/APrice Target and Rating Average Stock Price Target$7.00 High Stock Price Target$9.00 Low Stock Price Target$5.00 Potential Upside/Downside+2,723.7%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-11,260,000.00 Net MarginsN/A Pretax Margin-3,368.05% Return on Equity-80.81% Return on Assets-62.86% Debt Debt-to-Equity Ratio0.03 Current Ratio2.77 Quick Ratio2.77 Sales & Book Value Annual Sales$310,000.00 Price / Sales7.72 Cash FlowN/A Price / Cash FlowN/A Book Value$6.81 per share Price / Book0.04Miscellaneous Outstanding Shares9,660,000Free Float9,544,000Market Cap$2.39 million OptionableNo Data Beta0.98 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report This page (NASDAQ:NTBL) was last updated on 10/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredMusk warns humanity: “Obsolete”The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredWatch this before it gets removed If you missed it, my emergency election broadcast is now available - but will be removed soonPorter & Company | Sponsored #1 Pre-IPO Opportunity For 2024 [Take Action Now!]According to James, the largest IPO in history could kick off in a matter of weeks. I’m talking about Starl...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredGoldman Sachs’ AI warningAfter warning of last year's historic bank run, weeks in advance... Legendary stock-picker Marc Chaikin jus...Chaikin Analytics | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Notable Labs, Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Notable Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.